Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Recent Developments: 2025: Eli Lilly received FDA approval for tirzepatide (Zepbound) as a treatment for moderate-to-severe obstructive sleep apnea in adults with obesity the first pharmacotherapy approved for this indication expanding tirzepatide's approved uses beyond metabolic conditions into a respiratory indication affecting over 30 million Americans and supported by SURMOUNT-OSA trial data showing 63% reduction in apnea-hypopnea index
I have yet to get them as I am waiting to get paid
That said, this is not a do-it-yourself situation
Topical applications work locally and have a strong safety record in clinical reviews
US$ 21.44
US$ 29.63
US$ 26.78
US$ 24.38
US$ 20.75
US$ 26.11
